Dr Azad |
Professor
Peter Ebeling AO, Head, Department of Medicine is delighted to announce that medical
oncologist and researcher Dr Arun Azad, will take up appointments at Monash
Health and Monash University’s School of
Clinical Sciences (SCS)
in the second half of 2015 to focus on pre-clinical and clinical translational
research in genitourinary cancers.
Dr
Azad’s translational research will focus on the role of new chemotherapeutic
agents on castration-sensitive prostate cancer, leading to lead to improved
outcomes for patients with prostate cancer at Monash Health in the near future.
An
early-career medical oncologist and translational researcher in genitourinary
malignancies, Dr Azad currently leads cutting-edge work investigating
mechanisms of therapeutic resistance and response in advanced prostate cancer
patients through genomic analysis of circulating cell-free DNA (cfDNA) at the
British Columbia Cancer Agency, Vancouver, Canada.
Dr
Azad has played an active role in the development of five investigator-initiated
clinical trials and been the recipient of over $1.5M in competitive funding, including
a prestigious CJ Martin Fellowship from the NH&MRC.
His
clinical and research activities have resulted in publications in high-impact
journals including Journal of Clinical Oncology, European Urology
and Lancet Oncology. He has also been the recipient of 15 competitive
prizes and awards including Merit Awards at the American Society of Clinical Oncology
Annual Scientific Meeting and Genitourinary Cancers Symposium.
“It is tremendous we have been able to attract Dr Azad to
Monash University and Monash Health,” said Professor Ebeling.
“In addition to research excellence, he will be able to
translate his research findings into improving the outcomes of patients with
prostate cancer at Monash Health in the foreseeable future.”
No comments:
Post a Comment